Global Companion Diagnostics Industry

Global Companion Diagnostics Market to Reach $9. 2 Billion by 2027. Amid the COVID-19 crisis, the global market for Companion Diagnostics estimated at US$3. 4 Billion in the year 2020, is projected to reach a revised size of US$9.

New York, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Companion Diagnostics Industry" - https://www.reportlinker.com/p03915705/?utm_source=GNW
2 Billion by 2027, growing at aCAGR of 15.1% over the period 2020-2027. Assay kits & Reagents, one of the segments analyzed in the report, is projected to record 14.3% CAGR and reach US$6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software & Services segment is readjusted to a revised 16.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 14.6% CAGR

The Companion Diagnostics market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 14.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.5% and 13% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.1% CAGR.We bring years of research experience to this 18th edition of our report. The 248-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• Abbott Molecular

• Agilent Technologies, Inc.

• bioMérieux SA

• Cepheid

• Danaher Corporation

• F. Hoffmann-La Roche Ltd.

• Foundation Medicine Inc.

• Laboratory Corporation of America® Holdings

• Leica Biosystems Nussloch GmbH

• Merck & Co. Inc.

• Myriad Genetics Inc.

• NeoGenomics Laboratories, Inc.

• QIAGEN N.V.

• Quest Diagnostics Inc.

• Thermo Fischer Scientific Inc.

Read the full report: https://www.reportlinker.com/p03915705/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Companion Diagnostics: An Introductory Prelude
Quashing the One-Size-Fits-All Approach, CDx Wield Great
Promise for Streamlined Drug Discovery & Development
Broader Scope and Applications Rev Up Growth Opportunities
Healthy Growth Projected over the Next Few Years
Developed Regions: Key Revenue Contributors
Market Witnesses Fast Paced Growth in Developing Regions
Northbound Trajectory in R&D Spending Creates Conducive
Environment
Prevailing Economic Scenario Favors Funding Pattern
Global Competitor Market Shares
Companion Diagnostics Competitor Market Share Scenario
Worldwide (in %): 2018 & 2029

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Growing Significance of Personalized Medicine Remains a Major
Market Driver
Emphasis on Improving Targeted Therapies with CDx Tests Steers
Momentum
Herceptin Lays the Road for Companion Diagnostics
Oncology - Dominant Therapy Area for CDx
Rising Incidence of Cancer Propels the Need for CDx Tests
Technology Advancements to Widen CDx Use Case
PCR: Dominant Technology Type for CDx Testing
Next-Generation Sequencing (NGS) Gains Widespread Traction in
CDx Testing
Significant Role of Biomarkers in Companion Diagnostics
Critical Healthcare Needs of Aging Population Underpin CDx Sales
Regulatory Scenario Favors CDx Market
Resolving Prevailing Challenges: Critical for Future Growth of
CDx Market

4. GLOBAL MARKET PERSPECTIVE
Table 1: Companion Diagnostics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 2: Companion Diagnostics Market Share Shift across Key
Geographies Worldwide: 2020 VS 2027

Table 3: Assay kits & Reagents (Product & Service) World Market
by Region/Country in US$ Million: 2020 to 2027

Table 4: Assay kits & Reagents (Product & Service) Market Share
Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027

Table 5: Software & Services (Product & Service) Potential
Growth Markets Worldwide in US$ Million: 2020 to 2027

Table 6: Software & Services (Product & Service) Market Sales
Breakdown by Region/Country in Percentage: 2020 VS 2027

Table 7: Polymerase Chain Reaction (PCR) (Technology)
Geographic Market Spread Worldwide in US$ Million: 2020 to 2027

Table 8: Polymerase Chain Reaction (PCR) (Technology) Market
Share Distribution in Percentage by Region/Country: 2020 VS
2027

Table 9: Immunohistochemistry (IHC) (Technology) World Market
Estimates and Forecasts by Region/Country in US$ Million: 2020
to 2027

Table 10: Immunohistochemistry (IHC) (Technology) Market Share
Breakdown by Region/Country: 2020 VS 2027

Table 11: In Situ Hybridization (ISH) (Technology) World Market
by Region/Country in US$ Million: 2020 to 2027

Table 12: In Situ Hybridization (ISH) (Technology) Market Share
Distribution in Percentage by Region/Country: 2020 VS 2027

Table 13: Next-Generation Sequencing (NGS) (Technology) World
Market Estimates and Forecasts in US$ Million by
Region/Country: 2020 to 2027

Table 14: Next-Generation Sequencing (NGS) (Technology) Market
Percentage Share Distribution by Region/Country: 2020 VS 2027

Table 15: Other Technologies (Technology) Market Opportunity
Analysis Worldwide in US$ Million by Region/Country: 2020 to
2027

Table 16: Other Technologies (Technology) Market Share
Distribution in Percentage by Region/Country: 2020 VS 2027

Table 17: Oncology (Indication) World Market by Region/Country
in US$ Million: 2020 to 2027

Table 18: Oncology (Indication) Market Share Breakdown of
Worldwide Sales by Region/Country: 2020 VS 2027

Table 19: Neurology (Indication) Potential Growth Markets
Worldwide in US$ Million: 2020 to 2027

Table 20: Neurology (Indication) Market Sales Breakdown by
Region/Country in Percentage: 2020 VS 2027

Table 21: Other Indications (Indication) Geographic Market
Spread Worldwide in US$ Million: 2020 to 2027

Table 22: Other Indications (Indication) Market Share
Distribution in Percentage by Region/Country: 2020 VS 2027

Table 23: Pharmaceutical & Biopharmaceutical Companies
(End-Use) Worldwide Latent Demand Forecasts in US$ Million by
Region/Country: 2020-2027

Table 24: Pharmaceutical & Biopharmaceutical Companies
(End-Use) Distribution of Global Sales by Region/Country: 2020
VS 2027

Table 25: Reference Laboratories (End-Use) Sales Estimates and
Forecasts in US$ Million by Region/Country for the Years 2020
through 2027

Table 26: Reference Laboratories (End-Use) Global Market Share
Distribution by Region/Country for 2020 and 2027

Table 27: CROs (End-Use) Global Opportunity Assessment in US$
Million by Region/Country: 2020-2027

Table 28: CROs (End-Use) Percentage Share Breakdown of Global
Sales by Region/Country: 2020 VS 2027

Table 29: Other End-Uses (End-Use) Worldwide Sales in US$
Million by Region/Country: 2020-2027

Table 30: Other End-Uses (End-Use) Market Share Shift across
Key Geographies: 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Companion Diagnostics Market Share (in %) by Company: 2018 &
2025
Market Analytics
Table 31: United States Companion Diagnostics Market Estimates
and Projections in US$ Million by Product & Service: 2020 to
2027

Table 32: United States Companion Diagnostics Market Share
Breakdown by Product & Service: 2020 VS 2027

Table 33: Companion Diagnostics Market in US$ Million in the
United States by Technology: 2020-2027

Table 34: United States Companion Diagnostics Market Share
Breakdown by Technology: 2020 VS 2027

Table 35: United States Companion Diagnostics Market Estimates
and Projections in US$ Million by Indication: 2020 to 2027

Table 36: United States Companion Diagnostics Market Share
Breakdown by Indication: 2020 VS 2027

Table 37: United States Companion Diagnostics Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027

Table 38: Companion Diagnostics Market Share Breakdown in the
United States by End-Use: 2020 VS 2027

CANADA
Table 39: Canadian Companion Diagnostics Market Estimates and
Forecasts in US$ Million by Product & Service: 2020 to 2027

Table 40: Companion Diagnostics Market in Canada: Percentage
Share Breakdown of Sales by Product & Service for 2020 and 2027

Table 41: Companion Diagnostics Market Analysis in Canada in
US$ Million by Technology: 2020-2027

Table 42: Canadian Companion Diagnostics Market Share Breakdown
by Technology: 2020 VS 2027

Table 43: Canadian Companion Diagnostics Market Estimates and
Forecasts in US$ Million by Indication: 2020 to 2027

Table 44: Companion Diagnostics Market in Canada: Percentage
Share Breakdown of Sales by Indication for 2020 and 2027

Table 45: Canadian Companion Diagnostics Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027

Table 46: Canadian Companion Diagnostics Market Share Analysis
by End-Use: 2020 VS 2027

JAPAN
Table 47: Japanese Market for Companion Diagnostics: Annual
Sales Estimates and Projections in US$ Million by Product &
Service for the Period 2020-2027

Table 48: Japanese Companion Diagnostics Market Share Analysis
by Product & Service: 2020 VS 2027

Table 49: Japanese Medium & Long-Term Outlook for Companion
Diagnostics Market in US$ Million by Technology: 2020-2027

Table 50: Japanese Companion Diagnostics Market Percentage
Share Distribution by Technology: 2020 VS 2027

Table 51: Japanese Market for Companion Diagnostics: Annual
Sales Estimates and Projections in US$ Million by Indication
for the Period 2020-2027

Table 52: Japanese Companion Diagnostics Market Share Analysis
by Indication: 2020 VS 2027

Table 53: Japanese Demand Estimates and Forecasts for Companion
Diagnostics in US$ Million by End-Use: 2020 to 2027

Table 54: Companion Diagnostics Market Share Shift in Japan by
End-Use: 2020 VS 2027

CHINA
Table 55: Chinese Companion Diagnostics Market Growth Prospects
in US$ Million by Product & Service for the Period 2020-2027

Table 56: Chinese Companion Diagnostics Market by Product &
Service: Percentage Breakdown of Sales for 2020 and 2027

Table 57: Companion Diagnostics Market Estimates and Forecasts
in China in US$ Million by Technology: 2020-2027

Table 58: Companion Diagnostics Market in China: Percentage
Share Analysis by Technology for 2020 and 2027

Table 59: Chinese Companion Diagnostics Market Growth Prospects
in US$ Million by Indication for the Period 2020-2027

Table 60: Chinese Companion Diagnostics Market by Indication:
Percentage Breakdown of Sales for 2020 and 2027

Table 61: Chinese Demand for Companion Diagnostics in US$
Million by End-Use: 2020 to 2027

Table 62: Chinese Companion Diagnostics Market Share Breakdown
by End-Use: 2020 VS 2027

EUROPE
Market Facts & Figures
European Companion Diagnostics Market: Competitor Market Share
Scenario (in %) for 2018 & 2025
Market Analytics
Table 63: European Companion Diagnostics Market Demand Scenario
in US$ Million by Region/Country: 2018-2025

Table 64: European Companion Diagnostics Market Share Shift by
Region/Country: 2020 VS 2027

Table 65: European Companion Diagnostics Market Estimates and
Forecasts in US$ Million by Product & Service: 2020-2027

Table 66: European Companion Diagnostics Market Share Breakdown
by Product & Service: 2020 VS 2027

Table 67: European Companion Diagnostics Market Assessment in
US$ Million by Technology: 2020-2027

Table 68: Companion Diagnostics Market in Europe: Percentage
Breakdown of Sales by Technology for 2020 and 2027

Table 69: European Companion Diagnostics Market Estimates and
Forecasts in US$ Million by Indication: 2020-2027

Table 70: European Companion Diagnostics Market Share Breakdown
by Indication: 2020 VS 2027

Table 71: European Companion Diagnostics Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027

Table 72: European Companion Diagnostics Market Share Analysis
by End-Use: 2020 VS 2027

FRANCE
Table 73: Companion Diagnostics Market in France by Product &
Service: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 74: French Companion Diagnostics Market Share Analysis by
Product & Service: 2020 VS 2027

Table 75: French Companion Diagnostics Market Estimates and
Projections in US$ Million by Technology: 2020-2027

Table 76: French Companion Diagnostics Market Share Breakdown
by Technology: 2020 VS 2027

Table 77: Companion Diagnostics Market in France by Indication:
Estimates and Projections in US$ Million for the Period
2020-2027

Table 78: French Companion Diagnostics Market Share Analysis by
Indication: 2020 VS 2027

Table 79: Companion Diagnostics Quantitative Demand Analysis in
France in US$ Million by End-Use: 2020-2027

Table 80: French Companion Diagnostics Market Share Analysis:
A 7-Year Perspective by End-Use for 2020 and 2027

GERMANY
Table 81: Companion Diagnostics Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Product & Service
for the Period 2020-2027

Table 82: German Companion Diagnostics Market Share Breakdown
by Product & Service: 2020 VS 2027

Table 83: German Companion Diagnostics Latent Demand Forecasts
in US$ Million by Technology: 2020-2027

Table 84: German Companion Diagnostics Market Share Breakdown
by Technology: 2020 VS 2027

Table 85: Companion Diagnostics Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Indication for
the Period 2020-2027

Table 86: German Companion Diagnostics Market Share Breakdown
by Indication: 2020 VS 2027

Table 87: Companion Diagnostics Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 88: Companion Diagnostics Market Share Distribution in
Germany by End-Use: 2020 VS 2027

ITALY
Table 89: Italian Companion Diagnostics Market Growth Prospects
in US$ Million by Product & Service for the Period 2020-2027

Table 90: Italian Companion Diagnostics Market by Product &
Service: Percentage Breakdown of Sales for 2020 and 2027

Table 91: Companion Diagnostics Market Estimates and Forecasts
in Italy in US$ Million by Technology: 2020-2027

Table 92: Companion Diagnostics Market in Italy: Percentage
Share Analysis by Technology for 2020 and 2027

Table 93: Italian Companion Diagnostics Market Growth Prospects
in US$ Million by Indication for the Period 2020-2027

Table 94: Italian Companion Diagnostics Market by Indication:
Percentage Breakdown of Sales for 2020 and 2027

Table 95: Italian Demand for Companion Diagnostics in US$
Million by End-Use: 2020 to 2027

Table 96: Italian Companion Diagnostics Market Share Breakdown
by End-Use: 2020 VS 2027

UNITED KINGDOM
Table 97: United Kingdom Market for Companion Diagnostics:
Annual Sales Estimates and Projections in US$ Million by
Product & Service for the Period 2020-2027

Table 98: United Kingdom Companion Diagnostics Market Share
Analysis by Product & Service: 2020 VS 2027

Table 99: United Kingdom Medium & Long-Term Outlook for
Companion Diagnostics Market in US$ Million by Technology:
2020-2027

Table 100: United Kingdom Companion Diagnostics Market
Percentage Share Distribution by Technology: 2020 VS 2027

Table 101: United Kingdom Market for Companion Diagnostics:
Annual Sales Estimates and Projections in US$ Million by
Indication for the Period 2020-2027

Table 102: United Kingdom Companion Diagnostics Market Share
Analysis by Indication: 2020 VS 2027

Table 103: United Kingdom Demand Estimates and Forecasts for
Companion Diagnostics in US$ Million by End-Use: 2020 to 2027

Table 104: Companion Diagnostics Market Share Shift in the
United Kingdom by End-Use: 2020 VS 2027

REST OF EUROPE
Table 105: Rest of Europe Companion Diagnostics Market
Estimates and Forecasts in US$ Million by Product & Service:
2020-2027

Table 106: Rest of Europe Companion Diagnostics Market Share
Breakdown by Product & Service: 2020 VS 2027

Table 107: Rest of Europe Companion Diagnostics Market
Assessment in US$ Million by Technology: 2020-2027

Table 108: Companion Diagnostics Market in Rest of Europe:
Percentage Breakdown of Sales by Technology for 2020 and 2027

Table 109: Rest of Europe Companion Diagnostics Market
Estimates and Forecasts in US$ Million by Indication: 2020-2027

Table 110: Rest of Europe Companion Diagnostics Market Share
Breakdown by Indication: 2020 VS 2027

Table 111: Rest of Europe Companion Diagnostics Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 112: Rest of Europe Companion Diagnostics Market Share
Analysis by End-Use: 2020 VS 2027

ASIA-PACIFIC
Table 113: Companion Diagnostics Market in Asia-Pacific by
Product & Service: Estimates and Projections in US$ Million for
the Period 2020-2027

Table 114: Asia-Pacific Companion Diagnostics Market Share
Analysis by Product & Service: 2020 VS 2027

Table 115: Asia-Pacific Companion Diagnostics Market Estimates
and Projections in US$ Million by Technology: 2020-2027

Table 116: Asia-Pacific Companion Diagnostics Historic Market
Analysis in US$ Million by Technology: 2020 VS 2027

Table 117: Companion Diagnostics Market in Asia-Pacific by
Indication: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 118: Asia-Pacific Companion Diagnostics Market Share
Analysis by Indication: 2020 VS 2027

Table 119: Companion Diagnostics Quantitative Demand Analysis
in Asia-Pacific in US$ Million by End-Use: 2020-2027

Table 120: Asia-Pacific Companion Diagnostics Market Share
Analysis: A 7-Year Perspective by End-Use for 2020 and 2027

REST OF WORLD
Table 121: Rest of World Companion Diagnostics Market Estimates
and Forecasts in US$ Million by Product & Service: 2020 to 2027

Table 122: Companion Diagnostics Market in Rest of World:
Percentage Share Breakdown of Sales by Product & Service for
2020 and 2027

Table 123: Companion Diagnostics Market Analysis in Rest of
World in US$ Million by Technology: 2020-2027

Table 124: Rest of World Companion Diagnostics Market Share
Breakdown by Technology: 2020 VS 2027

Table 125: Rest of World Companion Diagnostics Market Estimates
and Forecasts in US$ Million by Indication: 2020 to 2027

Table 126: Companion Diagnostics Market in Rest of World:
Percentage Share Breakdown of Sales by Indication for 2020 and
2027

Table 127: Rest of World Companion Diagnostics Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 128: Rest of World Companion Diagnostics Market Share
Analysis by End-Use: 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 80
Read the full report: https://www.reportlinker.com/p03915705/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001